IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 363 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,459,000 | -31.5% | 25,809 | -42.5% | 0.01% | -38.5% |
| Q3 2020 | $2,131,000 | -6.0% | 44,919 | +16.8% | 0.01% | -7.1% |
| Q2 2020 | $2,267,000 | -36.7% | 38,449 | -49.2% | 0.01% | -46.2% |
| Q1 2020 | $3,581,000 | -73.1% | 75,733 | -63.5% | 0.03% | -71.4% |
| Q2 2019 | $13,319,000 | -20.9% | 207,238 | -0.2% | 0.09% | -19.5% |
| Q1 2019 | $16,848,000 | +50.1% | 207,565 | 0.0% | 0.11% | +34.5% |
| Q4 2018 | $11,221,000 | +8.2% | 207,565 | +3.3% | 0.08% | +47.4% |
| Q3 2018 | $10,366,000 | +19.4% | 200,977 | -3.6% | 0.06% | +11.8% |
| Q2 2018 | $8,684,000 | -7.3% | 208,405 | -1.9% | 0.05% | -10.5% |
| Q1 2018 | $9,364,000 | -12.8% | 212,425 | -0.5% | 0.06% | -6.6% |
| Q4 2017 | $10,740,000 | +2.4% | 213,524 | +3.3% | 0.06% | +8.9% |
| Q3 2017 | $10,484,000 | +2.9% | 206,784 | +3.3% | 0.06% | -1.8% |
| Q2 2017 | $10,187,000 | – | 200,258 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |